Form 4 Certara, Inc. For: Sep 09 Filed by: Pedersen Leif E
Certara, Inc. (CERT)
Company Research
Source: SEC EDGAR
Impact Snapshot
Event Time:
CERT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CERT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CERT alerts
High impacting Certara, Inc. news events
Weekly update
A roundup of the hottest topics
CERT
News
- Certara gains as UBS upgrades citing compelling buy [Seeking Alpha]Seeking Alpha
- Certara, Inc. (NASDAQ: CERT) was upgraded by analysts at UBS Group AG from a "neutral" rating to a "buy" rating. They now have a $16.00 price target on the stock.MarketBeat
- Certara’s Simcyp Consortium Celebrates 25th AnniversaryGlobeNewswire
- Following a 22% decline over last year, recent gains may please Certara, Inc. (NASDAQ:CERT) institutional owners [Yahoo! Finance]Yahoo! Finance
- Certara & Ichnos Glenmark Innovation Collaboration Optimizes Dosing Strategy for Potential First-In-Class Cancer DrugGlobeNewswire
CERT
Earnings
- 8/6/24 - In-Line
CERT
Sec Filings
- 9/9/24 - Form 144
- 8/6/24 - Form 10-Q
- 8/6/24 - Form 8-K
- CERT's page on the SEC website